Braveheart Bio, Inc.

BRVE Stock Healthcare Biotechnology
$18.71
-0.84 (-4.30%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-32.5%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Largest decline max drawdown, since Aug 2026
-38.1%

Own BRVE?

See how BRVE contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.